Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
Aim of investigation. To estimate efficacy of rifaximin in complex conservative treatment of chronic diverticulitis.Material and methods. The main group included 43 patients that received 200 mg rifaximin every 8 h within conservative treatment mode for 14 days. Of all patients 34 were women (79,1%)...
Saved in:
| Main Authors: | S. I. Achkasov, A. I. Moskalyov, Yu. L. Trubachyova, A. F. Filon |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2012-04-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study
by: Anna M. Pietrzak, et al.
Published: (2019-03-01) -
Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
by: Hyun Soo Kim, et al.
Published: (2020-09-01) -
Diverticular disease of the large intestine: current state of the problem
by: N. A. Lysov, et al.
Published: (2020-12-01) -
Role of Rifaximin in Prevention of Recurrent Hepatic Encephalopathy in Chronic Liver Disease
by: Sahar Farzand, et al.
Published: (2020-12-01) -
Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01)